BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32485671)

  • 21. Convergence on chromatin of non-genomic and genomic pathways of hormone signaling.
    Vicent GP; Ballaré C; Nacht AS; Clausell J; Subtil-Rodríguez A; Quiles I; Jordan A; Beato M
    J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):344-9. PubMed ID: 18417338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.
    Díaz Flaqué MC; Galigniana NM; Béguelin W; Vicario R; Proietti CJ; Russo R; Rivas MA; Tkach M; Guzmán P; Roa JC; Maronna E; Pineda V; Muñoz S; Mercogliano M; Charreau EH; Yankilevich P; Schillaci R; Elizalde PV
    Breast Cancer Res; 2013 Dec; 15(6):R118. PubMed ID: 24345432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.
    Gizard F; Robillard R; Gross B; Barbier O; Révillion F; Peyrat JP; Torpier G; Hum DW; Staels B
    Mol Cell Biol; 2006 Oct; 26(20):7632-44. PubMed ID: 17015480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms underlying progesterone receptor action in breast cancer: Insights into cell proliferation and stem cell regulation.
    Cenciarini ME; Proietti CJ
    Steroids; 2019 Dec; 152():108503. PubMed ID: 31562879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic agonism and phenotypic antagonism between estrogen and progesterone receptors in breast cancer.
    Singhal H; Greene ME; Tarulli G; Zarnke AL; Bourgo RJ; Laine M; Chang YF; Ma S; Dembo AG; Raj GV; Hickey TE; Tilley WD; Greene GL
    Sci Adv; 2016 Jun; 2(6):e1501924. PubMed ID: 27386569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progesterone receptor B recruits a repressor complex to a half-PRE site of the estrogen receptor alpha gene promoter.
    De Amicis F; Zupo S; Panno ML; Malivindi R; Giordano F; Barone I; Mauro L; Fuqua SA; Andò S
    Mol Endocrinol; 2009 Apr; 23(4):454-65. PubMed ID: 19147702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complex agonist-like properties of ICI 182,780 (Faslodex) in human breast cancer cells that predominantly express progesterone receptor-B: implications for treatment resistance.
    Wu J; Liang Y; Nawaz Z; Hyder SM
    Int J Oncol; 2005 Dec; 27(6):1647-59. PubMed ID: 16273221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Progesterone Receptors in Breast Cancer.
    Li Z; Wei H; Li S; Wu P; Mao X
    Drug Des Devel Ther; 2022; 16():305-314. PubMed ID: 35115765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear factor 1 synergizes with progesterone receptor on the mouse mammary tumor virus promoter wrapped around a histone H3/H4 tetramer by facilitating access to the central hormone-responsive elements.
    Vicent GP; Zaurin R; Nacht AS; Font-Mateu J; Le Dily F; Beato M
    J Biol Chem; 2010 Jan; 285(4):2622-31. PubMed ID: 19940123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.
    Calvo V; Beato M
    Cancer Res; 2011 May; 71(9):3422-31. PubMed ID: 21531767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.
    Wei M; He Q; Yang Z; Wang Z; Zhang Q; Liu B; Gu Q; Su L; Yu Y; Zhu Z; Zhang G
    BMC Cancer; 2014 Jan; 14():10. PubMed ID: 24401087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer.
    Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD
    Clin Cancer Res; 2004 Jul; 10(13):4417-9. PubMed ID: 15240531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deep sequencing reveals new aspects of progesterone receptor signaling in breast cancer cells.
    Kougioumtzi A; Tsaparas P; Magklara A
    PLoS One; 2014; 9(6):e98404. PubMed ID: 24897521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclin D1 enhances the response to estrogen and progesterone by regulating progesterone receptor expression.
    Yang C; Chen L; Li C; Lynch MC; Brisken C; Schmidt EV
    Mol Cell Biol; 2010 Jun; 30(12):3111-25. PubMed ID: 20404095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FGF2 induces breast cancer growth through ligand-independent activation and recruitment of ERα and PRBΔ4 isoform to MYC regulatory sequences.
    Giulianelli S; Riggio M; Guillardoy T; Pérez Piñero C; Gorostiaga MA; Sequeira G; Pataccini G; Abascal MF; Toledo MF; Jacobsen BM; Guerreiro AC; Barros A; Novaro V; Monteiro FL; Amado F; Gass H; Abba M; Helguero LA; Lanari C
    Int J Cancer; 2019 Oct; 145(7):1874-1888. PubMed ID: 30843188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligand activated progesterone receptor B drives autophagy-senescence transition through a Beclin-1/Bcl-2 dependent mechanism in human breast cancer cells.
    De Amicis F; Guido C; Santoro M; Giordano F; Donà A; Rizza P; Pellegrino M; Perrotta I; Bonofiglio D; Sisci D; Panno ML; Tramontano D; Aquila S; Andò S
    Oncotarget; 2016 Sep; 7(36):57955-57969. PubMed ID: 27462784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromatin reprogramming in breast cancer.
    Swinstead EE; Paakinaho V; Hager GL
    Endocr Relat Cancer; 2018 Jul; 25(7):R385-R404. PubMed ID: 29692347
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The hormone regulatory element of mouse mammary tumour virus mediates progesterone induction.
    Cato AC; Miksicek R; Schütz G; Arnemann J; Beato M
    EMBO J; 1986 Sep; 5(9):2237-40. PubMed ID: 3023063
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ligand-dependent cross-talk between steroid and thyroid hormone receptors. Evidence for common transcriptional coactivator(s).
    Zhang X; Jeyakumar M; Bagchi MK
    J Biol Chem; 1996 Jun; 271(25):14825-33. PubMed ID: 8662980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.